Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Gurbaxani

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Epidemics|May 8, 2026
Some mathematical reasons why meta-analyses of nonpharmaceutical interventions like facemasks could be inaccurateBrian M Gurbaxani
BMC Bioinformatics|October 15, 2010
Quadratic variance models for adaptively preprocessing SELDI-TOF mass spectrometry dataVincent A Emanuele, Brian M Gurbaxani
Proteomics|March 19, 2009
Benchmarking currently available SELDI-TOF MS preprocessing techniquesVincent A Emanuele, Brian M Gurbaxani
American Journal of Public Health|February 9, 2024
Gurbaxani et al. RespondBrian M Gurbaxani, Andrew N Hill, Pragna Patel
American Journal of Public Health|September 6, 2023
Unpacking Cochrane's Update on Masks and COVID-19Brian M Gurbaxani, Andrew N Hill, Pragna Patel
Theoretical Biology & Medical Modelling|February 16, 2007
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistabilityShakti Gupta, Eric Aslakson, Brian M Gurbaxani, et al.
Neuromolecular Medicine|October 14, 2010
Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease associationVirginia R Falkenberg, Brian M Gurbaxani, Elizabeth R Unger, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 9, 2017
A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donorsPallavi D Annambhotla, Brian M Gurbaxani, Matthew J Kuehnert, et al.
Clinical Pharmacokinetics|January 10, 2013
Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodiesMiroslav Dostalek, Iain Gardner, Brian M Gurbaxani, et al.
Pharmacogenomics|April 14, 2006
Linear data mining the Wichita clinical matrix suggests sleep and allostatic load involvement in chronic fatigue syndromeBrian M Gurbaxani, James F Jones, Benjamin N Goertzel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Epidemics|May 8, 2026
Some mathematical reasons why meta-analyses of nonpharmaceutical interventions like facemasks could be inaccurateBrian M Gurbaxani
BMC Bioinformatics|October 15, 2010
Quadratic variance models for adaptively preprocessing SELDI-TOF mass spectrometry dataVincent A Emanuele, Brian M Gurbaxani
Proteomics|March 19, 2009
Benchmarking currently available SELDI-TOF MS preprocessing techniquesVincent A Emanuele, Brian M Gurbaxani
American Journal of Public Health|February 9, 2024
Gurbaxani et al. RespondBrian M Gurbaxani, Andrew N Hill, Pragna Patel
American Journal of Public Health|September 6, 2023
Unpacking Cochrane's Update on Masks and COVID-19Brian M Gurbaxani, Andrew N Hill, Pragna Patel
Theoretical Biology & Medical Modelling|February 16, 2007
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistabilityShakti Gupta, Eric Aslakson, Brian M Gurbaxani, et al.
Neuromolecular Medicine|October 14, 2010
Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease associationVirginia R Falkenberg, Brian M Gurbaxani, Elizabeth R Unger, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 9, 2017
A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donorsPallavi D Annambhotla, Brian M Gurbaxani, Matthew J Kuehnert, et al.
Clinical Pharmacokinetics|January 10, 2013
Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodiesMiroslav Dostalek, Iain Gardner, Brian M Gurbaxani, et al.
Pharmacogenomics|April 14, 2006
Linear data mining the Wichita clinical matrix suggests sleep and allostatic load involvement in chronic fatigue syndromeBrian M Gurbaxani, James F Jones, Benjamin N Goertzel, et al.
Pageof 2